Eris Lifesciences Ltd announces the acquisition of Nephrology and Dermatology business units of Biocon Biologics in India, with a deal consideration of INR 366 crore and expected revenue run-rate of INR 100 crore.
AI Assistant
ERIS Lifesciences Ltd
2023
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.